Crossroads Capital Inc (XRDC) : Radcliffe Capital Management scooped up 57,691 additional shares in Crossroads Capital Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 210,891 shares of Crossroads Capital Inc which is valued at $430,218.Crossroads Capital Inc makes up approximately 16.07% of Radcliffe Capital Management’s portfolio.
Other Hedge Funds, Including , Rivernorth Capital Management boosted its stake in XRDC in the latest quarter, The investment management firm added 25,994 additional shares and now holds a total of 579,042 shares of Crossroads Capital Inc which is valued at $1,181,246. Crossroads Capital Inc makes up approx 0.07% of Rivernorth Capital Management’s portfolio. Vantage Investment Advisors added XRDC to its portfolio by purchasing 610 company shares during the most recent quarter which is valued at $1,244.Wfg Advisors Lp reduced its stake in XRDC by selling 3,876 shares or 10.82% in the most recent quarter. The Hedge Fund company now holds 31,960 shares of XRDC which is valued at $65,198. Crossroads Capital Inc makes up approx 0.02% of Wfg Advisors Lp’s portfolio.Tower Research Capital (trc) reduced its stake in XRDC by selling 200 shares or 26.32% in the most recent quarter. The Hedge Fund company now holds 560 shares of XRDC which is valued at $1,142. Integrated Wealth Management sold out all of its stake in XRDC during the most recent quarter. The investment firm sold 522 shares of XRDC which is valued $1,138.
Crossroads Capital Inc. formerly BDCA Venture Inc. is a closed-end fund regulated as a business development company under the 1940 Act. The Fund’s investment objective is to maximize total return by generating current income from debt investments and to a lesser extent capital appreciation from equity and equity-related investments. Its investment strategy focuses on making secured and unsecured debt investments in companies. It may also invest in equity or equity-related investments alongside debt investments. The Fund will primarily focus on companies in the technology healthcare life sciences and energy industries. The Fund intends to primarily make debt investments in privately held growth companies across various stages of development including early later and growth stage companies as well as lower middle market companies.